1988, ISBN 9780704409934, iii, 157
Book
Archives of Toxicology, ISSN 0340-5761, 05/2011, Volume 85, Issue 5, pp. 367 - 485
The 7th amendment to the EU Cosmetics Directive prohibits to put animal-tested cosmetics on the market in Europe after 2013. In that context, the European...
Toxicokinetics | Repeated dose toxicity | Carcinogenicity | Alternative methods | Reproductive toxicity | Skin sensitisation | Biomedicine | Environmental Health | Occupational Medicine/Industrial Medicine | Pharmacology/Toxicology | Biomedicine general | STEM-CELL TEST | IN-VIVO EXTRAPOLATION | LYMPH-NODE ASSAY | PIG MAXIMIZATION TEST | QUANTITATIVE RISK-ASSESSMENT | TOXICOLOGICAL CONCERN TTC | VITRO GENOTOXICITY TESTS | INCORPORATING MOLECULAR FLEXIBILITY | TOXICOLOGY | DISCRIMINATE RODENT CARCINOGENS | VOLATILE ORGANIC-COMPOUNDS | Risk Assessment - methods | Guidelines as Topic | Reproducibility of Results | Carcinogenicity Tests - methods | Humans | Animal Testing Alternatives - standards | Biological Availability | Toxicity Tests - trends | Animal Testing Alternatives - trends | Animals | Consumer Product Safety - legislation & jurisprudence | Cosmetics - standards | European Union | Toxicity Tests - methods | Risk Assessment - trends | Skin - drug effects | Animal experimentation | Medical colleges | Allergy | Environmental health | Green technology | Cosmetics | Scientists | Allergic reaction | Consulting services | Methods | Public health | Cosmetics industry | Product testing | Laboratory animals | Toxicity | Life Sciences | Toxicology | Environmental Sciences
Toxicokinetics | Repeated dose toxicity | Carcinogenicity | Alternative methods | Reproductive toxicity | Skin sensitisation | Biomedicine | Environmental Health | Occupational Medicine/Industrial Medicine | Pharmacology/Toxicology | Biomedicine general | STEM-CELL TEST | IN-VIVO EXTRAPOLATION | LYMPH-NODE ASSAY | PIG MAXIMIZATION TEST | QUANTITATIVE RISK-ASSESSMENT | TOXICOLOGICAL CONCERN TTC | VITRO GENOTOXICITY TESTS | INCORPORATING MOLECULAR FLEXIBILITY | TOXICOLOGY | DISCRIMINATE RODENT CARCINOGENS | VOLATILE ORGANIC-COMPOUNDS | Risk Assessment - methods | Guidelines as Topic | Reproducibility of Results | Carcinogenicity Tests - methods | Humans | Animal Testing Alternatives - standards | Biological Availability | Toxicity Tests - trends | Animal Testing Alternatives - trends | Animals | Consumer Product Safety - legislation & jurisprudence | Cosmetics - standards | European Union | Toxicity Tests - methods | Risk Assessment - trends | Skin - drug effects | Animal experimentation | Medical colleges | Allergy | Environmental health | Green technology | Cosmetics | Scientists | Allergic reaction | Consulting services | Methods | Public health | Cosmetics industry | Product testing | Laboratory animals | Toxicity | Life Sciences | Toxicology | Environmental Sciences
Journal Article
Mutation Research - Genetic Toxicology and Environmental Mutagenesis, ISSN 1383-5718, 05/2015, Volume 783, pp. 55 - 65
This report summarizes the discussion, conclusions, and points of consensus of the IWGT Working Group on Quantitative Approaches to Genetic Toxicology Risk...
Points of departure | Quantitative risk assessment | Genotoxicity | Benchmark dose | PREDICTING RODENT CARCINOGENICITY | LIMITS | THRESHOLD | GENETIC TOXICITY ASSAYS | POTENCY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | TOXICOLOGY | Neoplasms - metabolism | Mutagens - toxicity | Risk Assessment | Humans | DNA - metabolism | Mutagenicity Tests - methods | DNA - genetics | Neoplasms - chemically induced | Neoplasms - genetics | Models, Genetic | Mutation | Neoplasms - pathology | Mutagenicity Tests - standards | Mutagens - analysis | Benchmarks | Biosafety | Consulting services | Risk assessment | Methods
Points of departure | Quantitative risk assessment | Genotoxicity | Benchmark dose | PREDICTING RODENT CARCINOGENICITY | LIMITS | THRESHOLD | GENETIC TOXICITY ASSAYS | POTENCY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | TOXICOLOGY | Neoplasms - metabolism | Mutagens - toxicity | Risk Assessment | Humans | DNA - metabolism | Mutagenicity Tests - methods | DNA - genetics | Neoplasms - chemically induced | Neoplasms - genetics | Models, Genetic | Mutation | Neoplasms - pathology | Mutagenicity Tests - standards | Mutagens - analysis | Benchmarks | Biosafety | Consulting services | Risk assessment | Methods
Journal Article
Environmental Health Perspectives, ISSN 0091-6765, 06/2016, Volume 124, Issue 6, pp. 713 - 721
BACKGROUND: A recent review by the International Agency for Research on Cancer (IARC) updated the assessments of the > 100 agents classified as Group 1,...
EPIGENETIC MECHANISMS | SIGNALING PATHWAYS | BENZENE-INDUCED LEUKEMIA | NUCLEAR RECEPTORS | CANCER HALLMARK | ENVIRONMENTAL SCIENCES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | LOW-DOSE EXPOSURES | CHEMICAL-MIXTURES | ETHYLENE-OXIDE | TOXICOLOGY | MOLECULAR-MECHANISMS | DRUG-METABOLISM | Risk Assessment - methods | Animals | Polychlorinated Biphenyls - toxicity | Carcinogenicity Tests - methods | Humans | Carcinogenicity Tests - standards | Carcinogens - standards | Benzene - toxicity | Carcinogenesis | Carcinogens - toxicity | Risk Assessment - standards | Monographs | Hydrocarbons | Gene expression | Epidemiology | Chemicals | Data bases | Studies | Carcinogens | Toxicology | Polychlorinated biphenyls--PCB | Tumors | Cancer | Index Medicus | Review
EPIGENETIC MECHANISMS | SIGNALING PATHWAYS | BENZENE-INDUCED LEUKEMIA | NUCLEAR RECEPTORS | CANCER HALLMARK | ENVIRONMENTAL SCIENCES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | LOW-DOSE EXPOSURES | CHEMICAL-MIXTURES | ETHYLENE-OXIDE | TOXICOLOGY | MOLECULAR-MECHANISMS | DRUG-METABOLISM | Risk Assessment - methods | Animals | Polychlorinated Biphenyls - toxicity | Carcinogenicity Tests - methods | Humans | Carcinogenicity Tests - standards | Carcinogens - standards | Benzene - toxicity | Carcinogenesis | Carcinogens - toxicity | Risk Assessment - standards | Monographs | Hydrocarbons | Gene expression | Epidemiology | Chemicals | Data bases | Studies | Carcinogens | Toxicology | Polychlorinated biphenyls--PCB | Tumors | Cancer | Index Medicus | Review
Journal Article
1984, Contemporary biomedicine, ISBN 9780896030428, xvii, 335
Book
1988, Rev. ed. --, ISBN 9780444809698, 484
Book
Food and Chemical Toxicology, ISSN 0278-6915, 08/2017, Volume 106, Issue Pt B, pp. 574 - 582
Chemical contaminants and residues are undesired chemicals occurring in consumer products such as food and drugs, at the workplace and in the environment, i.e....
Genotoxicity testing | Residues | Carcinogenicity | Contaminants | Risk assessment | Genotoxicity | HEALTH-RISK | DNA-ADDUCTS | SAFETY ASSESSMENT | FOOD SCIENCE & TECHNOLOGY | TOXICITY | ON-A-CHIP | TOXICOLOGICAL CONCERN TTC | SCIENTIFIC OPINION | THRESHOLD | DECISION TREE | TOXICOLOGY | FOOD | Hazard Analysis and Critical Control Points - methods | Risk Assessment - methods | Animals | Food Contamination - analysis | Humans | Mutagenicity Tests - methods | Mutagenicity Tests - standards | Mutagens - analysis | Consumer goods | Dioxin | Food contamination | Methods | Index Medicus
Genotoxicity testing | Residues | Carcinogenicity | Contaminants | Risk assessment | Genotoxicity | HEALTH-RISK | DNA-ADDUCTS | SAFETY ASSESSMENT | FOOD SCIENCE & TECHNOLOGY | TOXICITY | ON-A-CHIP | TOXICOLOGICAL CONCERN TTC | SCIENTIFIC OPINION | THRESHOLD | DECISION TREE | TOXICOLOGY | FOOD | Hazard Analysis and Critical Control Points - methods | Risk Assessment - methods | Animals | Food Contamination - analysis | Humans | Mutagenicity Tests - methods | Mutagenicity Tests - standards | Mutagens - analysis | Consumer goods | Dioxin | Food contamination | Methods | Index Medicus
Journal Article
8.
Full Text
Refinement, reduction, and replacement of animal toxicity tests by computational methods
ILAR Journal, ISSN 1084-2020, 2016, Volume 57, Issue 2, pp. 226 - 233
Widespread public and scientific interest in promoting the care and well-being of animals used for toxicity testing has given rise to improvements in animal...
3Rs | Drug development | Computational toxicology | QSAR | In silico prediction | Alternative testing method | READ-ACROSS | STRUCTURAL INCLUSION RULES | drug development | IN-SILICO TOOLS | in silico prediction | DECISION-SUPPORT-SYSTEM | PREDICTION | alternative testing method | MODELS | CARCINOGENICITY | SPECIES-DIFFERENCES | VETERINARY SCIENCES | CHEMICAL-SUBSTANCES | computational toxicology | HEPATOTOXICITY | Toxicity Tests - methods | Animal Welfare | Animals | Research | Animal Use Alternatives
3Rs | Drug development | Computational toxicology | QSAR | In silico prediction | Alternative testing method | READ-ACROSS | STRUCTURAL INCLUSION RULES | drug development | IN-SILICO TOOLS | in silico prediction | DECISION-SUPPORT-SYSTEM | PREDICTION | alternative testing method | MODELS | CARCINOGENICITY | SPECIES-DIFFERENCES | VETERINARY SCIENCES | CHEMICAL-SUBSTANCES | computational toxicology | HEPATOTOXICITY | Toxicity Tests - methods | Animal Welfare | Animals | Research | Animal Use Alternatives
Journal Article
Regulatory Toxicology and Pharmacology, ISSN 0273-2300, 06/2016, Volume 77, pp. 13 - 24
The ICH M7 guideline describes a consistent approach to identify, categorize, and control DNA reactive, mutagenic, impurities in pharmaceutical products to...
Mutagenic impurities | Impurities | Ames test | Expert review | Toxicity databases | ICH M7 | (Q)SAR | SALMONELLA ASSAY | MEDICINE, LEGAL | CHEMICAL RELATIONAL DATABASES | IN-SILICO SYSTEMS | STRATEGIES | PREDICTION | GENOTOXICITY | CARCINOGENICITY | PHARMACOLOGY & PHARMACY | POTENTIALLY MUTAGENIC IMPURITIES | TOXICOLOGY | EXPERT KNOWLEDGE | Mutagens - chemistry | Guidelines as Topic | Mutagens - toxicity | Toxicology - legislation & jurisprudence | Risk Assessment | Carcinogenicity Tests - methods | Humans | Toxicology - standards | Carcinogenicity Tests - standards | Models, Molecular | Mutagenicity Tests - methods | Animals | Guideline Adherence | Mutagenesis | Computer Simulation | Policy Making | Molecular Structure | DNA Damage | Toxicology - methods | Mutagens - classification | Data Mining - methods | Mutagenicity Tests - standards | Quantitative Structure-Activity Relationship | Databases, Factual | Index Medicus
Mutagenic impurities | Impurities | Ames test | Expert review | Toxicity databases | ICH M7 | (Q)SAR | SALMONELLA ASSAY | MEDICINE, LEGAL | CHEMICAL RELATIONAL DATABASES | IN-SILICO SYSTEMS | STRATEGIES | PREDICTION | GENOTOXICITY | CARCINOGENICITY | PHARMACOLOGY & PHARMACY | POTENTIALLY MUTAGENIC IMPURITIES | TOXICOLOGY | EXPERT KNOWLEDGE | Mutagens - chemistry | Guidelines as Topic | Mutagens - toxicity | Toxicology - legislation & jurisprudence | Risk Assessment | Carcinogenicity Tests - methods | Humans | Toxicology - standards | Carcinogenicity Tests - standards | Models, Molecular | Mutagenicity Tests - methods | Animals | Guideline Adherence | Mutagenesis | Computer Simulation | Policy Making | Molecular Structure | DNA Damage | Toxicology - methods | Mutagens - classification | Data Mining - methods | Mutagenicity Tests - standards | Quantitative Structure-Activity Relationship | Databases, Factual | Index Medicus
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 07/2007, Volume 82, Issue 1, pp. 70 - 80
In vivo studies represent an essential step in drug development and currently rely largely on mice, yet limitations of mammalian models motivated the search...
TRANSGENIC ZEBRAFISH | POTENT INHIBITOR | POSITIONAL CLONING | EMBRYO | SCREEN | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | PHARMACOLOGY & PHARMACY | INSERTIONAL MUTAGENESIS | MUTATIONS | CANCER | Drug Evaluation, Preclinical - methods | Mutagens - toxicity | Reproducibility of Results | Embryo, Nonmammalian - pathology | Carcinogenicity Tests - methods | Humans | Gene Expression Regulation, Developmental - drug effects | Antineoplastic Agents - therapeutic use | Mutagenicity Tests - methods | Zebrafish - embryology | Embryo, Nonmammalian - drug effects | Zebrafish - genetics | Carcinogens - toxicity | Animals | Neoplasms, Experimental - embryology | Drug Design | Models, Animal | Toxicity Tests - methods | Antineoplastic Agents - pharmacology | Cell Transformation, Neoplastic - drug effects | DNA Damage | Gene Expression Regulation, Neoplastic - drug effects | Neoplasms, Experimental - drug therapy
TRANSGENIC ZEBRAFISH | POTENT INHIBITOR | POSITIONAL CLONING | EMBRYO | SCREEN | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | PHARMACOLOGY & PHARMACY | INSERTIONAL MUTAGENESIS | MUTATIONS | CANCER | Drug Evaluation, Preclinical - methods | Mutagens - toxicity | Reproducibility of Results | Embryo, Nonmammalian - pathology | Carcinogenicity Tests - methods | Humans | Gene Expression Regulation, Developmental - drug effects | Antineoplastic Agents - therapeutic use | Mutagenicity Tests - methods | Zebrafish - embryology | Embryo, Nonmammalian - drug effects | Zebrafish - genetics | Carcinogens - toxicity | Animals | Neoplasms, Experimental - embryology | Drug Design | Models, Animal | Toxicity Tests - methods | Antineoplastic Agents - pharmacology | Cell Transformation, Neoplastic - drug effects | DNA Damage | Gene Expression Regulation, Neoplastic - drug effects | Neoplasms, Experimental - drug therapy
Journal Article